COMMUNIQUÉS West-GlobeNewswire

NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
07/05/2026
SIM0505/CDH6 ADC dose optimization initiated in gynecologic cancers SIM0505 Phase 1 dose escalation study data to be presented at ASCO 2026 LNCB74 Phase 1 dose escalation trial update planned in second half of 2026 [...]
STERIS Appoints Pierre Boulud to Board of Directors
07/05/2026
DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. “We are [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
07/05/2026
CONSHOHOCKEN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis [...]
Nephros Announces Financial Results for Quarter Ended March 31, 2026
07/05/2026
First-Quarter Net Revenue Growth of 7% to $5.2 million; Core Programmatic Revenue Grew by 23% Year Over Year SOUTH ORANGE, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology [...]
Codexis Reports First Quarter 2026 Financial Results
07/05/2026
Reports revenue of $15.2 million for the first quarter, company reiterates full-year financial guidance Three presentations at upcoming TIDES USA annual meeting to feature new data for ECO Synthesis manufacturing [...]
ICU Medical Announces First Quarter 2026 Results
07/05/2026
SAN CLEMENTE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the [...]
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2026
WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, [...]
Profound Medical Reports Strong First Quarter 2026 Financial Results
07/05/2026
– Quarterly results marked by 104% revenue growth and improved operating performance – – Company issues full-year 2026 revenue guidance – – Announces Humana is now covering the TULSA Procedure™ – TORONTO, May 07, 2026 ( [...]
LeMaitre to Present at the Bank of America Healthcare Conference
07/05/2026
BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM [...]
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
07/05/2026
-- Topline data from randomized Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 -- -- Systemic lung cancer programs advancing with additional updates expected throughout 2026 [...]
The Helios Alliance Applauds Dr. Rahul Gupta's Appointment to Knoa Foundation Board of Trustees
07/05/2026
Leadership team member brings national expertise to oversight of pharmaceutical company emerging from Purdue Pharma settlement, advancing transparency and accountability in opioid abatement nationwide Mobile, ALABAMA, [...]
Serotonin Centers Highlights 5-Day Live Training Program as Cornerstone of Franchise Support and Performance
07/05/2026
Proven, Hands-On Training Model Drives Consistency, Team Confidence, and Client Outcomes Across National Footprint ORLANDO, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Serotonin Centers, a national leader in science-backed [...]
TOMI Environmental Solutions’ Binary Ionization Technology Approved in Additional European Union Countries
07/05/2026
FREDERICK, Md., May 07, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that its Binary Ionization [...]
BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease
07/05/2026
Oral presentation at ISCT 2026 included larger 52-week follow-up cohort, with 52% of evaluable patients achieving at least 50% improvement in both VAS pain and ODI function measures and no dose-limiting toxicity safety [...]
Strengthening Mental Health and Psychosocial Support Preparedness in Emergencies
07/05/2026
Canadian Red Cross launches new program to support Canadians impacted by emergencies OTTAWA, Ontario, May 07, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross has announced the Strengthening Mental Health and [...]
INVIAH Launches Beta in Chicago: The Doctor Comes to You
07/05/2026
Co-founders Dr. Yevhen Pavelko and Natallia Panysh introduce a physician home-visit platform, powered by proprietary AI technology, that addresses systemic failures in U.S. healthcare access, bringing in-person medical [...]
SK pharmteco collabore avec Axle Informatics et les Instituts nationaux de la santé afin de développer des programmes de thérapie génique pour les maladies rares
07/05/2026
RANCHO CORDOVA, Californie, 07 mai 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé ce jour un partenariat stratégique avec Axle Informatics et les Instituts nationaux de la santé (NIH) en vue de promouvoir le [...]
Renforcement des services en santé mentale et bien-être en préparation aux situations d’urgence
07/05/2026
La Croix-Rouge canadienne lance un nouveau programme en soutien aux personnes touchées par une situation d’urgence au pays OTTAWA, Ontario, 07 mai 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne annonce le lancement [...]
Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
07/05/2026
Submission supports advancement of a long‑term, fully implantable, blood‑based continuous glucose monitoring platform RUTHERFORD, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or [...]

Pages